Linzess (linaclotide) is a prescription medicine that helps ease constipation caused by irritable bowel syndrome (IBS-C). It works by drawing more fluid into your intestines, which makes it easier for stool to pass. The FDA… Read more
Keytruda Qlex is a new form of pembrolizumab, a cancer-fighting lab-made antibody that helps your immune system find and attack cancer cells. Unlike the original 30-minute intravenous (IV) drip, the Keytruda Qlex shot is a… Read more
Blenrep (belantamab mafodotin-blmf) is a type of cancer medicine called an antibody-drug conjugate. It works by finding and attaching to a protein called B-cell maturation antigen (BCMA), which is found on multiple myeloma cells. Once… Read more
Revuforj (revumenib) is an oral medicine approved for treating a type of cancer called acute myeloid leukemia (AML) that affects your bone marrow and blood. In 2024, Revuforj became the first approved medicine for treating… Read more
Lynkuet (elinzanetant) is a new nonhormonal medicine taken by mouth to help manage moderate to severe hot flashes linked to menopause. Hot flashes, also called vasomotor symptoms (VMS), can cause sudden feelings of heat, sweating,… Read more
Rhapsido (remibrutinib) is a new oral medicine approved to treat adults with chronic spontaneous urticaria (CSU). CSU is a long-term skin condition that causes itchy hives or swelling without a clear cause. It can last… Read more
Zoryve (roflumilast) cream is a prescription steroid-free medicine for treating inflammatory skin conditions such as atopic dermatitis (eczema) and plaque psoriasis. Zoryve works by blocking an enzyme called PDE4 (phosphodiesterase 4). This in turn helps… Read more
The FDA has approved Simponi (golimumab) for children with moderately to severely active ulcerative colitis (UC) who weigh at least 15 kilograms (33 pounds). Simponi is a lab-made antibody (biologic medicine) that works by blocking… Read more
Forzinity (elamipretide) is the first medicine to receive accelerated approval from the FDA for improving muscle strength in people with Barth syndrome who weigh at least 66 pounds (30 kilograms). Barth syndrome is an extremely… Read more
Jascayd (nerandomilast) is a new oral medicine approved to treat idiopathic pulmonary fibrosis (IPF) in adults. IPF is a rare and serious condition that causes scarring (fibrosis) in the lungs that worsens over time, making… Read more